Chargement en cours...
Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease
PURPOSE: This article reviews the efficacy and safety of revefenacin, the first once-daily, long-acting muscarinic antagonist, when delivered via a standard jet nebulizer in patients with chronic obstructive pulmonary disease (COPD). SUMMARY: Revefenacin 175 µg is indicated for the maintenance treat...
Enregistré dans:
| Publié dans: | Am J Health Syst Pharm |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8083528/ https://ncbi.nlm.nih.gov/pubmed/33821890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajhp/zxab154 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|